Open access · CC-BY
via OpenAlex
Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma
Amany Marwan, Omar Ahmed Elmetwally, Mohamed M. Marwan, Mohamed Mohamed Adel El‐Sokkary, Shimaa Ali Abass, Laila Ahmed Eissa
Scientific Reports · 2025 · ▲ 7 citations
Abstract
Egypt has the greatest incidence of hepatitis C virus (HCV) infection globally, which is a considerable trigger of fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The gut microbiome has been recognized for contributing to various hepatic conditions. Nevertheless, its correlation with HCV and HCC is not well understood. Our study is conducted to investigate the potential relevance of some biomarkers: matrix metalloproteinase 9 (MMP9), Signal transducer and activator of transcription 3 (STAT3), superoxide dismutase (SOD), vascular endothelial growth factor (VEGF), and nuclear factor-κB (NF-κB), along with gut microbial variations, for the differentiation between HCV-related cirrhosis and HCC. The 90 fecal and blood samples were collected from 30 healthy controls, 30 HCV-related cirrhosis, and 30 HCC for detecting gut microbial abundance and biochemical markers examination. Our findings displayed the existence of intestinal microbiome dysbiosis with marked enrichment of specific species, including Bifidobacterium, Fusobacterium, Providencia, E. faecium, and Pseudomonas aeruginosa in HCC patients. Furthermore, the most enriched genera in HCV-related cirrhosis patients were Bifidobacterium, Porphyromonas, and Bacteroides. MMP9 exhibited the highest diagnostic performance of the five measured biomarkers, discriminating against HCC vs. HCV-related cirrhosis with specificity and sensitivity of 100% and 90%, respectively, at a cut-off value > 166.8. Additionally, SOD and NF-κB were statistically significant discriminators of HCC from cirrhosis at cutoff values of ≤ 0.197 and > 166.8. A significant correlation between microbiome abundance and VEGF and MMP9 was observed. This study illustrated that gut microbiomes contribute to HCC and HCV-related cirrhosis pathogenesis, opening approaches for cancer management and prevention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41598-025-28663-6
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Marwan, A., Elmetwally, O.A., Marwan, M.M., El‐Sokkary, M.M.A., Abass, S.A., & Eissa, L.A. (2025). Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. <em>Scientific Reports</em>. https://doi.org/10.1038/s41598-025-28663-6
Vancouver
Marwan A, Elmetwally OA, Marwan MM, El‐Sokkary MMA, Abass SA, Eissa LA. Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. Scientific Reports. 2025. doi:10.1038/s41598-025-28663-6.
BibTeX
@article{amany2025Diagno,
title = {Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma},
author = {Amany Marwan and Omar Ahmed Elmetwally and Mohamed M. Marwan and Mohamed Mohamed Adel El‐Sokkary and Shimaa Ali Abass and Laila Ahmed Eissa},
journal = {Scientific Reports},
year = {2025},
doi = {10.1038/s41598-025-28663-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomedicines 2022
Open access · CC-BY
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Pediatric Diabetes 2019
Open access · OA
Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study
Nature Communications 2021
Open access · CC-BY
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance
BMC Microbiology 2022
Open access · CC-BY
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Progress in molecular biology and translational science 2022
Citation only
Gut microbiome dysbiosis in neonatal sepsis
iScience 2026
Open access · CC-BY